Bank of Nova Scotia Trust’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.57M | Buy |
5,125
+536
| +12% | +$257K | 0.21% | 65 |
|
|
2026
Q1 | $2.26M | Buy |
4,589
+1,707
| +59% | +$926K | 0.19% | 65 |
|
|
2025
Q4 | $1.67M | Sell |
2,882
-38
| -1% | -$21.5K | 0.15% | 77 |
|
|
2025
Q3 | $1.42M | Sell |
2,920
-545
| -16% | -$254K | 0.13% | 78 |
|
|
2025
Q2 | $1.4M | Buy |
3,465
+283
| +9% | +$118K | 0.14% | 75 |
|
|
2025
Q1 | $1.58M | Buy |
3,182
+661
| +26% | +$358K | 0.17% | 67 |
|
|
2024
Q4 | $1.31M | Buy |
2,521
+93
| +4% | +$51.1K | 0.14% | 75 |
|
|
2024
Q3 | $1.5M | Buy |
2,428
+133
| +6% | +$78.7K | 0.15% | 72 |
|
|
2024
Q2 | $1.27M | Sell |
2,295
-122
| -5% | -$69.9K | 0.14% | 73 |
|
|
2024
Q1 | $1.4M | Sell |
2,417
-561
| -19% | -$315K | 0.15% | 72 |
|
|
2023
Q4 | $1.58M | Buy |
2,978
+63
| +2% | +$30.5K | 0.18% | 64 |
|
|
2023
Q3 | $1.48M | Sell |
2,915
-4
| -0.1% | -$2.13K | 0.18% | 65 |
|
|
2023
Q2 | $1.52M | Buy |
2,919
+1,814
| +164% | +$979K | 0.16% | 65 |
|
|
2023
Q1 | $637K | Sell |
1,105
-427
| -28% | -$241K | 0.07% | 88 |
|
|
2022
Q4 | $844K | Sell |
1,532
-29
| -2% | -$15.4K | 0.09% | 81 |
|
|
2022
Q3 | $792K | Sell |
1,561
-188
| -11% | -$105K | 0.09% | 79 |
|
|
2022
Q2 | $950K | Buy |
1,749
+407
| +30% | +$224K | 0.1% | 73 |
|
|
2022
Q1 | $793K | Sell |
1,342
-58
| -4% | -$33.3K | 0.07% | 89 |
|
|
2021
Q4 | $934K | Buy |
1,400
+935
| +201% | +$584K | 0.08% | 85 |
|
|
2021
Q3 | $266K | Sell |
465
-88
| -16% | -$48.3K | 0.02% | 125 |
|
|
2021
Q2 | $279K | Sell |
553
-40
| -7% | -$18.9K | 0.02% | 120 |
|
|
2021
Q1 | $271K | Hold |
593
| – | – | 0.03% | 119 |
|
|
2020
Q4 | $276K | Sell |
593
-64
| -10% | -$30K | 0.03% | 115 |
|
|
2020
Q3 | $290K | Buy |
657
+31
| +5% | +$12.8K | 0.04% | 96 |
|
|
2020
Q2 | $227K | Sell |
626
-168
| -21% | -$56.3K | 0.03% | 95 |
|
|
2020
Q1 | $225K | Buy |
+794
| New | +$250K | 0.03% | 95 |
|
|
2019
Q3 | – | Sell |
-727
| Closed | -$214K | – | 125 |
|
|
2019
Q2 | $214K | Buy |
+727
| New | +$200K | 0.03% | 116 |
|
|
2017
Q4 | – | Sell |
-558
| Closed | -$106K | – | 364 |
|
|
2017
Q3 | $106K | Buy |
+558
| New | +$101K | 0.01% | 175 |
|
|
2016
Q1 | – | Sell |
-5,000
| Closed | -$709K | – | 114 |
|
|
2015
Q4 | $709K | Hold |
5,000
| – | – | 0.11% | 73 |
|
|
2015
Q3 | $611K | Hold |
5,000
| – | – | 0.09% | 84 |
|
|
2015
Q2 | $655K | Hold |
5,000
| – | – | 0.08% | 86 |
|
|
2015
Q1 | $672K | Buy |
+5,000
| New | +$645K | 0.09% | 81 |
|
|
2014
Q4 | – | Sell |
-1,890
| Closed | -$230K | – | 117 |
|
|
2014
Q3 | $230K | Buy |
+1,890
| New | +$230K | 0.03% | 111 |
|
Other funds holding TMO
Bank of Nova Scotia Trust's TMO Position: Q2 2026 in Review
Bank of Nova Scotia Trust increased its Thermo Fisher Scientific (TMO) stake by 12% in Q2 2026, buying an estimated $257K and bringing the position to 5,125 shares worth $2.57M. The position accounts for 0.21% of the portfolio, ranked #65.
Bank of Nova Scotia Trust first reported a position in TMO in Q3 2014 and has held it in 33 quarters since. 2,630 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Bank of Nova Scotia Trust held 5,125 shares of Thermo Fisher Scientific worth $2.57M as of Q2 2026.
- Bank of Nova Scotia Trust bought 536 Thermo Fisher Scientific shares in Q2 2026, an estimated $257K.
- Thermo Fisher Scientific made up 0.21% of Bank of Nova Scotia Trust's portfolio in Q2 2026, its #65 holding.
- Bank of Nova Scotia Trust first reported a position in Thermo Fisher Scientific in Q3 2014 and has held it in 33 quarters since.
- 2,630 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Bank of Nova Scotia Trust's 13F filing for Q2 2026, filed 11 Aug 2026.